SCHEMBL8288981

SCHEMBL8288981

CC(=O)Nc1ccc(C(=O)N[C@H](C(=O)N2CCC[C@H]2C=O)C(C)C)c(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.45
TAAR1 Q96RJ0 1/20 0.41
PREP P48147 4/20 0.40
FAP Q12884 1/20 0.39
ALDH1A1 P00352 1/20 0.39
THRB P10828 1/20 0.39
DPP4 P27487 1/20 0.39
DPP8 Q6V1X1 1/20 0.39
DPP9 Q86TI2 1/20 0.39
HSD11B1 P28845 2/20 0.39
RORC P51449 2/20 0.39
ACE2 Q9BYF1 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HDAC1 Q13547 1/20 0.38
HTT P42858 1/20 0.37
CHRM5 P08912 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8288972 0.89 PREP (0.51) NPC1PREPFAPDPP4DPP8
SCHEMBL8288021 0.88 STAT6 (0.41) PREPFAPHSD11B1RORCCYP1A2
SCHEMBL14181581 0.88 NPC1 (0.48) NPC1TAAR1PREPFAPALDH1A1
SCHEMBL14181473 0.86 HSD11B1 (0.42) NPC1PREPFAPHSD11B1RORC
SCHEMBL3173952 0.86 CYP3A4 (0.47) NPC1TAAR1PREPFAPALDH1A1
SCHEMBL8288902 0.85 TAAR1 (0.49) NPC1TAAR1PREPFAPALDH1A1
SCHEMBL8287675 0.85 NPC1 (0.46) NPC1TAAR1PREPFAPDPP4
SCHEMBL8288020 0.84 NPC1 (0.46) NPC1TAAR1PREPFAPALDH1A1
SCHEMBL12031661 0.84 PSMB5 (0.48) NPC1TAAR1PREPFAPDPP4
SCHEMBL8288844 0.83 CASP1 (0.44) NPC1TAAR1CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2399916-A1 Process and intermediates for the preparation of aspartic acetal caspase ihnhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-12-28 EP disclosed
US-7381827-B2 5-Ethoxy-4-(1-(benzyloxycarbonyl)-2-pyrrolidinylcarbonylamino)-5H-furan-2-one; purification by chromatography, selectively crystallization, or dynamic crystallization; useful for preparing caspase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-06-03 US disclosed
WO-2005085236-A2 CASPASE INHIBITORS AND USES THEREOF VERTEX PHARMACEUTICALS INCORPORATED (US) 2005-09-15 WO disclosed